The UFC is hosting fights at the White House tonight. Here's what you need to know: 1. The UFC is spending $60 million to put on this event. That's way more than the $3-4 million the company typically spends to put on an event and three times the $20 million it spent at the Las Vegas Sphere in 2024. 2. The UFC sold $30 million in corporate sponsorship deals — Ram Trucks, Crypto(.)com, Polymarket, Bud Light — with individual packages selling for $1.5 million. 3. Since tickets are being given out for free, the event is expected to lose about $30 million. 4. The UFC's $7.7 billion media rights deal with Paramount allows some fights to be simulcast on CBS, but tonight's entire event will only be available on the Paramount streaming service. 5. There will be 4,000 people on the South Lawn for the event — Trump controls about 1,000 tickets, with Dana White and Ari Emanuel controlling another 500 or so. The remaining seats were given to active duty military members. These military members had to meet body composition standards and pay for their own travel. 6. The UFC installed a giant arch over the octagon known as the Claw. The structure is massive — 60 tons, 154 feet wide, and 92 feet high, with a 100-by-100-foot canopy and 800 lighting fixtures — and since the UFC isn't allowed to dig into the South Lawn, engineers added 40 tons of weight to each leg to hold it down. 7. The Claw was flown from Belgium to Philadelphia, test-assembled in Philly, and then trucked down to DC. Each truck was placed in storage before being searched by the Secret Service, and the UFC needed 38 days to assemble everything (compared to their normal 2 days). 8. The UFC is covering all production costs, but taxpayers are still on the hook for $10-12 million in supplemental security costs. The White House says this money would have been spent anyway and that it comes from a federal fund (approved by Congress) specifically allocated for events surrounding the country's 250th birthday. 9. Since attendance on the South Lawn is invite-only (and limited to 4,000 people), the UFC is holding a watch party at the Eliipise. Roughly 85,000 tickets have been distributed for free, and while the UFC plans to sell food, beverages, and merchandise, Dana White told ESPN that "the government will get a piece of it." 10. Every fighter will be wearing custom red, white, and blue gloves with an American flag stitched on the wrist. BONUS: Trump's latest financial disclosure indicates that he purchased up to $50,000 in TKO stock, the parent company of the UFC. Some say this is a conflict of interest, while others claim it is insignificant, given that his full financial disclosure included over 3,700 stock and bond trades worth more than $220 million. That's it for today. Enjoy the event, and if you want to learn more about the business and money behind sports, join 135,000 others who read my newsletter. Sign up: huddleup.substack.com/

It'll be interesting to see if any of the 3 get attacked. At least this massive shit show is entertaining. 😂

1962 1964 1968 1970 1972 1974 1976 1978 1980 1982 1984 1986 1988 1990 1992 1994 1996 1998 2000 2002 2004 2006 2008 2010 2012 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2034 2036 ... ...??

BREAKING: Largest Human Cancer Study of Ivermectin Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a MAJOR Cancer Journal 84.4% of cancer patients taking ivermectin mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION. Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995. The results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology. A diverse population of cancer patients (n=197) was prescribed compounded ivermectin–mebendazole through a U.S. telemedicine platform, with each capsule containing 25 mg ivermectin and 250 mg mebendazole. Participants were followed for approximately six months using standardized digital surveys assessing cancer outcomes, medication adherence, and tolerability. At approximately six months post-treatment initiation, we observed an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either: No evidence of disease (32.8%) Tumor regression (15.6%) or Cancer stabilization (36.1%) Importantly, adherence was remarkably high, with 86.9% completing the initial prescription and 66.4% remaining on therapy at six months. Side effects were predominantly mild and manageable, reported in 25.4% of patients (primarily gastrointestinal), with 93.6% of those experiencing side effects continuing treatment after minor dosing adjustments. This groundbreaking peer-reviewed publication was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel—uniting real-world clinical data, frontline medical experience, and epidemiologic expertise to evaluate inexpensive, repurposed therapies with major translational potential. With these extraordinarily promising results, double-blind, placebo-controlled clinical trials are now required. In the meantime, many cancer patients are exercising their right to try. @twc_health @McCulloughFund @IIAR_Journals @P_McCulloughMD @DrHarveyRisch @DrKellyVictory @jathorpmfm @drdrew @PeterGillooly @FosterCoulson

I'm feeling the same, total disconnect from the matrix. Just not interested in engaging anymore🤷🏻‍♂️

The Rep. Luna (R-FL) Amendment No. 28 Adopted - 280 Yeas, 142 Nays